Analysis published in the American Society of Nephrology highlighted strong evidence that ERAs benefit chronic kidney disease ...
Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
By Nancy Lapid Jan 22 (Reuters) - Many patients using highly effective GLP-1 drugs like Wegovy may not regain lost weight ...
CHOP receives $10 million grant for project that uses clinical data analysis to combat rare diseases
The Center for Data Driven Discovery in Biomedicine at the Children's Hospital of Philadelphia received a $10 million federal grant for the development of Real-time Analysis and Discovery in ...
Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer The authors present a score that ...
Uncovering mechanisms regulating immune system responses is key to strengthening and redirecting them whenever necessary in cancer and infections as well as understanding autoimmune diseases. However, ...
Patients’ financial resources affect their enrollment in oncology clinical trials to a greater degree than traditional ...
New generative AI integration automates clinical documentation to prioritize patient care and improve operational ...
Sitryx advances development of PKM2 modulator SYX-5219 into atopic dermatitis patients following clinical evidence of immunomodulatory activity First-in-class, oral PKM2 modulator, SYX-5219, has the ...
Data presented at CTAD showed strong separation from placebo and statistical significance in mild-to-moderate patients on key global, cognitive, and behavioral measures including CDR-SB, ADAS- Cog 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results